Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore - PubMed (original) (raw)
. 2008 Jul 11;31(1):134-42.
doi: 10.1016/j.molcel.2008.05.005.
Jennifer L Rocnik, Rafael Bernad, Benjamin H Lee, Dena Leeman, Olga Gielen, Hanne Verachtert, Cedric Folens, Sebastian Munck, Peter Marynen, Maarten Fornerod, D Gary Gilliland, Jan Cools
Affiliations
- PMID: 18614052
- DOI: 10.1016/j.molcel.2008.05.005
Free article
Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore
Kim De Keersmaecker et al. Mol Cell. 2008.
Free article
Abstract
Genetic alterations causing constitutive tyrosine kinase activation are observed in a broad spectrum of cancers. Thus far, these mutant kinases have been localized to the plasma membrane or cytoplasm, where they engage proliferation and survival pathways. We report that the NUP214-ABL1 fusion is unique among these because of its requisite localization to the nuclear pore complex for its transforming potential. We show that NUP214-ABL1 displays attenuated transforming capacity as compared to BCR-ABL1 and that NUP214-ABL1 preferentially transforms T cells, which is in agreement with its unique occurrence in T cell acute lymphoblastic leukemia. Furthermore, NUP214-ABL1 differs from BCR-ABL1 in subcellular localization, initiation of kinase activity, and signaling and lacks phosphorylation on its activation loop. In addition to delineating an unusual mechanism for kinase activation, this study provides new insights into the spectrum of chromosomal translocations involving nucleoporins by indicating that the nuclear pore context itself may play a central role in transformation.
Similar articles
- ABL1 fusions in T-cell acute lymphoblastic leukemia.
De Keersmaecker K. De Keersmaecker K. Verh K Acad Geneeskd Belg. 2008;70(4):245-55. Verh K Acad Geneeskd Belg. 2008. PMID: 19166098 Review. - Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.
Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, Bosly A, Heimann P, Uyttebroeck A, Mentens N, Somers R, MacLeod RA, Drexler HG, Look AT, Gilliland DG, Michaux L, Vandenberghe P, Wlodarska I, Marynen P, Hagemeijer A. Graux C, et al. Nat Genet. 2004 Oct;36(10):1084-9. doi: 10.1038/ng1425. Epub 2004 Sep 12. Nat Genet. 2004. PMID: 15361874 - Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
De Keersmaecker K, Versele M, Cools J, Superti-Furga G, Hantschel O. De Keersmaecker K, et al. Leukemia. 2008 Dec;22(12):2208-16. doi: 10.1038/leu.2008.242. Epub 2008 Sep 11. Leukemia. 2008. PMID: 18784740 - ABL1 rearrangements in T-cell acute lymphoblastic leukemia.
Hagemeijer A, Graux C. Hagemeijer A, et al. Genes Chromosomes Cancer. 2010 Apr;49(4):299-308. doi: 10.1002/gcc.20743. Genes Chromosomes Cancer. 2010. PMID: 20073070 Review. - Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A, Deau B, Brahim W, Staal A, Visanica S, Villarese P, Rault JP, Macintyre E, Delabesse E. Sindt A, et al. Genes Chromosomes Cancer. 2006 Jun;45(6):575-82. doi: 10.1002/gcc.20320. Genes Chromosomes Cancer. 2006. PMID: 16518848
Cited by
- The nuclear envelope environment and its cancer connections.
Chow KH, Factor RE, Ullman KS. Chow KH, et al. Nat Rev Cancer. 2012 Feb 16;12(3):196-209. doi: 10.1038/nrc3219. Nat Rev Cancer. 2012. PMID: 22337151 Free PMC article. Review. - Role of ABL family kinases in cancer: from leukaemia to solid tumours.
Greuber EK, Smith-Pearson P, Wang J, Pendergast AM. Greuber EK, et al. Nat Rev Cancer. 2013 Aug;13(8):559-71. doi: 10.1038/nrc3563. Epub 2013 Jul 11. Nat Rev Cancer. 2013. PMID: 23842646 Free PMC article. Review. - The role of nuclear pores in gene regulation, development and disease.
Capelson M, Hetzer MW. Capelson M, et al. EMBO Rep. 2009 Jul;10(7):697-705. doi: 10.1038/embor.2009.147. Epub 2009 Jun 19. EMBO Rep. 2009. PMID: 19543230 Free PMC article. Review. - Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and NUP214-ABL1 fusion: A case report.
Chen Y, Zhang L, Huang J, Hong X, Zhao J, Wang Z, Zhang K. Chen Y, et al. Exp Ther Med. 2017 Nov;14(5):3979-3984. doi: 10.3892/etm.2017.5046. Epub 2017 Aug 28. Exp Ther Med. 2017. PMID: 29067094 Free PMC article. - SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.
Brown LM, Hediyeh-Zadeh S, Sadras T, Huckstep H, Sandow JJ, Bartolo RC, Kosasih HJ, Davidson NM, Schmidt B, Bjelosevic S, Johnstone R, Webb AI, Khaw SL, Oshlack A, Davis MJ, Ekert PG. Brown LM, et al. Blood Adv. 2022 Apr 12;6(7):2373-2387. doi: 10.1182/bloodadvances.2021006076. Blood Adv. 2022. PMID: 35061886 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous